Skip to main content
Top
Published in: Familial Cancer 3/2010

01-09-2010

Differences in clinical and pathological characteristics of colorectal cancer in Arab as compared to Jewish patients in Northern Israel

Authors: Yelena Glushko, Walid Basher, Micha Barchana, Jamal Zidan

Published in: Familial Cancer | Issue 3/2010

Login to get access

Abstract

The Incidence of colorectal cancer (CRC) differs in different ethnic groups. The aim of this study is to investigate clinical and pathological features of CRC in Arab as compared to Jewish patients in Northern Israel. Clinical and pathological characteristics of 480 patients with CRC treated between 1999 and 2006 were retrospectively reviewed. Eighty-five percent of the patients were Jews and 15% were Arabs. Mean age at diagnosis was 67.1 years in Jews and 58.3 years in Arabs (P < 0.001). Stage I CRC was 17.5% versus 7.2% (P < 0.05), Stage II was 35.5% versus 27.5% (P < 0.01), Stage III was 26% versus 33.3% (P:0 < 0.01) and Stage IV 21% versus 31% (P < 0.01) in Jewish and Arab patients respectively. In 40.6% of Jewish patients, cancer was well differentiated compared to 27.1% of Arab patients (P < 0.01) and poorly differentiated in 5.5% versus 10,4% (P < 0.05). Abdominal pain, constipation and weight loss were more common in Arabs than in Jews (P < 0.05). In conclusion CRC is more advanced, more aggressive and more symptomatic in Arab than in Jewish patients. Arab patients are younger at the time of diagnosis. Screening for CRC should be started at earlier age in the Arab population than the population at large.
Literature
1.
go back to reference American Cancer Society (2005) Colorectal cancer: facts and figures. American Cancer Society, Atlanta Special Edition American Cancer Society (2005) Colorectal cancer: facts and figures. American Cancer Society, Atlanta Special Edition
2.
go back to reference Israel Cancer Registry: Cancer in Israel (1993) State of Israel. Israel Ministry of Health, Department of Epidemiology, Jerusalem Israel Cancer Registry: Cancer in Israel (1993) State of Israel. Israel Ministry of Health, Department of Epidemiology, Jerusalem
4.
go back to reference Barchana M, Liphshitz I, Rosen P (2004) Trends in colorectal cancer incidence and mortality in Israeli Jewish ethnic population. Fam Cancer 3:207–214CrossRefPubMed Barchana M, Liphshitz I, Rosen P (2004) Trends in colorectal cancer incidence and mortality in Israeli Jewish ethnic population. Fam Cancer 3:207–214CrossRefPubMed
7.
go back to reference Haenzel W (1982) Migrant studies. In: Schottenfeld D, Fraumeni JR (eds) Cancer epidemiology and prevention. WB Saunders, Philadelphia, pp 194–199 Haenzel W (1982) Migrant studies. In: Schottenfeld D, Fraumeni JR (eds) Cancer epidemiology and prevention. WB Saunders, Philadelphia, pp 194–199
8.
go back to reference Haenszel W (1961) Cancer mortality among the foreign born in the United States. J Natl Cancer Inst 26:37–52PubMed Haenszel W (1961) Cancer mortality among the foreign born in the United States. J Natl Cancer Inst 26:37–52PubMed
9.
go back to reference Steinmetz KA, Potter JD (1966) Vegetables, fruit, and cancer prevention: a review. J Am Diet Assoc 10:1027–1039 Steinmetz KA, Potter JD (1966) Vegetables, fruit, and cancer prevention: a review. J Am Diet Assoc 10:1027–1039
10.
go back to reference Fireman Z, Sandler E, Kopelman Y et al (2001) Ethnic difference in colorectal cancer among Arab and Jewish neighbors in Israel. Am J Gastroenterol 96:204–207CrossRefPubMed Fireman Z, Sandler E, Kopelman Y et al (2001) Ethnic difference in colorectal cancer among Arab and Jewish neighbors in Israel. Am J Gastroenterol 96:204–207CrossRefPubMed
11.
12.
go back to reference Rex DK, Lehman GA, Ulbright TM et al (1993) Colonic neoplasia in asymptomatic persons with negative fecal occult blood tests: influence of age, gender, and family history. Am J Gastroenterol 88:825–831PubMed Rex DK, Lehman GA, Ulbright TM et al (1993) Colonic neoplasia in asymptomatic persons with negative fecal occult blood tests: influence of age, gender, and family history. Am J Gastroenterol 88:825–831PubMed
14.
go back to reference McMichael AJ, Giles GG (1988) Cancer in migrants to Australia: extending the descriptive epidemiological data. Cancer Res 48:751–756PubMed McMichael AJ, Giles GG (1988) Cancer in migrants to Australia: extending the descriptive epidemiological data. Cancer Res 48:751–756PubMed
15.
go back to reference Israel Central Bureau of Statistics (2005) The Arab population in Israel 2003. Ministry of Health, Jerusalem, Israel Israel Central Bureau of Statistics (2005) The Arab population in Israel 2003. Ministry of Health, Jerusalem, Israel
16.
go back to reference Azaiza F (2006) Adolescent girls in distress: views from Arab female adolescents living in Israel. Int Social Work 49:188–197CrossRef Azaiza F (2006) Adolescent girls in distress: views from Arab female adolescents living in Israel. Int Social Work 49:188–197CrossRef
17.
go back to reference Green MS (1998) Differences between Israeli Jews and Arabs in morbidity and mortality rates for diseases potentially associated with dietary risk factors. Public Health Rev 26:31–40PubMed Green MS (1998) Differences between Israeli Jews and Arabs in morbidity and mortality rates for diseases potentially associated with dietary risk factors. Public Health Rev 26:31–40PubMed
18.
go back to reference Ministry of Health (1998) Trends in cancer incidence, and mortality in Israel, 1995. Publication No. 207: 1970 Ministry of Health (1998) Trends in cancer incidence, and mortality in Israel, 1995. Publication No. 207: 1970
19.
go back to reference Fireman Z, Neiman E, Abu Mouch S et al (2005) Trends in incidence of colorectal cancer in Jewish and Arab populations in central Israel. Digestion 72(4):223–227CrossRefPubMed Fireman Z, Neiman E, Abu Mouch S et al (2005) Trends in incidence of colorectal cancer in Jewish and Arab populations in central Israel. Digestion 72(4):223–227CrossRefPubMed
Metadata
Title
Differences in clinical and pathological characteristics of colorectal cancer in Arab as compared to Jewish patients in Northern Israel
Authors
Yelena Glushko
Walid Basher
Micha Barchana
Jamal Zidan
Publication date
01-09-2010
Publisher
Springer Netherlands
Published in
Familial Cancer / Issue 3/2010
Print ISSN: 1389-9600
Electronic ISSN: 1573-7292
DOI
https://doi.org/10.1007/s10689-010-9337-6

Other articles of this Issue 3/2010

Familial Cancer 3/2010 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine